Close Menu

NIDCR

The NIH will provide funding for the statistical analysis of existing genome-wide data related to human dental, oral, or craniofacial biology.

The MD Anderson researchers aim to combine computational and functional approaches to investigate genomic alterations as novel therapeutic targets.

NEW YORK (GenomeWeb) – The National Institute of Dental and Craniofacial Research will award $2 million to small businesses developing point-of-care diagnostic tests that detect oral pathogens or use biomarkers to screen for, monitor, and diagnose oral diseases.

NEW YORK (GenomeWeb News) – The National Institute of Dental and Craniofacial Research plans to award $1.5 million next year to fund researchers delving into the molecular and cell-level biology of cancer initiating cells (CICs), also called cancer stem cells, which may be involved in oral cancer

NEW YORK (GenomeWeb News) – The National Institute of Dental and Craniofacial Research plans to award up to $5 million next year for basic, translational, and preclinical studies aiming to discover the epigenetic basis of oral diseases that are caused by viruses.

NEW YORK (GenomeWeb News) – The National Cancer Institute plans to fund a number of research centers over the next two years with grants supporting translational research projects that focus on cancers of specific organs.

NEW YORK (GenomeWeb News) – Researchers at the University of Miami School of Medicine plan to use a five-year, $2.5 million grant from the National Institute of Dental and Craniofacial Research to discover DNA variants that may function as biomarkers for susceptibility and therapeutic response fo

The National Institute of Dental and Craniofacial Research has set aside $2 million this year to support the development of 'omics-based approaches and mouse models for studying salivary gland tumors.

An NCI and NIDCR grant program will support science aimed at discovering signatures for infection-associated cancers.

Pages

Two COVID-19 vaccine developers have released their trial protocols to build public trust, the New York Times reports.

A new analysis finds the rapid COVID-19 test from DnaNudge to be highly accurate, Reuters reports.

In Science this week: global citizens' assembly on genome-editing technologies proposed, epigenetic markers predict metformin response, and more.

According to the Verge, many US states are not including positive results from rapid COVID-19 testing in their case numbers.